Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine H Davis

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Proceedings (Baylor University. Medical Center)|January 4, 2024
Resistant gastroenteropancreatic neuroendocrine tumors: a definition and guideline to medical and surgical managementCatherine H Davis, Amanda M Laird, Steven K Libutti
The Journal of Surgical Research|January 30, 2019
Trends and Outcomes for Minimally Invasive Surgery for Inflammatory Bowel DiseaseTanmay Gaglani, Catherine H Davis, Harold R Bailey, et al.
International Journal of Surgery Case Reports|July 6, 2021
Simultaneous primary invasive breast carcinoma and ipsilateral cutaneous melanoma of the back: Surgical approach and considerations, a case reportNicole K Fosko, Catherine H Davis, Vadim P Koshenkov, et al.
Proceedings (Baylor University. Medical Center)|April 28, 2025
Characteristics and outcomes of observed versus resected pancreatic neuroendocrine tumorsCaroline Breit, Bobby Dow, Masen Ragsdale, et al.
Journal of Investigative Medicine High Impact Case Reports|December 21, 2022
Disease Control Achieved Using Atezolizumab + Bevacizumab in a Patient With Sarcomatoid Hepatocellular Carcinoma (SHCC), a Rare Variant Excluded From the IMbrave150 TrialMaria G Fencer, Catherine H Davis, Jieqi Liu, et al.
Journal of Surgical Oncology|March 6, 2022
Effect of the COVID-19 pandemic on surgical oncology practice-Results of an SSO surveyYelizaveta Gribkova, Catherine H Davis, Alissa A Greenbaum, et al.
International Journal of Surgery Case Reports|October 11, 2016
A multidisciplinary approach to giant soft tissue sarcoma of the chest wall: A case reportCatherine H Davis, Halim Yammine, Puja G Khaitan, et al.
Surgery|January 13, 2018
A proactive outreach intervention that decreases readmission after hepatectomyNisha Narula, Bradford J Kim, Catherine H Davis, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 28, 2019
Detours on the Road to Recovery: What Factors Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection for Malignancy?Heather A Lillemoe, Rebecca K Marcus, Bradford J Kim, et al.
Annals of Surgical Oncology|November 30, 2022
Chronologic Age, Independent of Frailty, is the Strongest Predictor of Failure-to-Rescue After Surgery for Gastrointestinal MalignanciesMatthew A Beier, Catherine H Davis, Maria G Fencer, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Proceedings (Baylor University. Medical Center)|January 4, 2024
Resistant gastroenteropancreatic neuroendocrine tumors: a definition and guideline to medical and surgical managementCatherine H Davis, Amanda M Laird, Steven K Libutti
The Journal of Surgical Research|January 30, 2019
Trends and Outcomes for Minimally Invasive Surgery for Inflammatory Bowel DiseaseTanmay Gaglani, Catherine H Davis, Harold R Bailey, et al.
International Journal of Surgery Case Reports|July 6, 2021
Simultaneous primary invasive breast carcinoma and ipsilateral cutaneous melanoma of the back: Surgical approach and considerations, a case reportNicole K Fosko, Catherine H Davis, Vadim P Koshenkov, et al.
Proceedings (Baylor University. Medical Center)|April 28, 2025
Characteristics and outcomes of observed versus resected pancreatic neuroendocrine tumorsCaroline Breit, Bobby Dow, Masen Ragsdale, et al.
Journal of Investigative Medicine High Impact Case Reports|December 21, 2022
Disease Control Achieved Using Atezolizumab + Bevacizumab in a Patient With Sarcomatoid Hepatocellular Carcinoma (SHCC), a Rare Variant Excluded From the IMbrave150 TrialMaria G Fencer, Catherine H Davis, Jieqi Liu, et al.
Journal of Surgical Oncology|March 6, 2022
Effect of the COVID-19 pandemic on surgical oncology practice-Results of an SSO surveyYelizaveta Gribkova, Catherine H Davis, Alissa A Greenbaum, et al.
International Journal of Surgery Case Reports|October 11, 2016
A multidisciplinary approach to giant soft tissue sarcoma of the chest wall: A case reportCatherine H Davis, Halim Yammine, Puja G Khaitan, et al.
Surgery|January 13, 2018
A proactive outreach intervention that decreases readmission after hepatectomyNisha Narula, Bradford J Kim, Catherine H Davis, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 28, 2019
Detours on the Road to Recovery: What Factors Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection for Malignancy?Heather A Lillemoe, Rebecca K Marcus, Bradford J Kim, et al.
Annals of Surgical Oncology|November 30, 2022
Chronologic Age, Independent of Frailty, is the Strongest Predictor of Failure-to-Rescue After Surgery for Gastrointestinal MalignanciesMatthew A Beier, Catherine H Davis, Maria G Fencer, et al.
Pageof 4